/
/
/

Shree Ganesh Bio-Tech (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)0.48
Volume (₹)6.28 L
High (₹)0.48
Upper Circuit0.57
Low (₹)0.47
Lower Circuit0.39
Prev Close0.48
52W High (₹)0.78
Price0.48
52W Low (₹)0.46

Share Market Cap & Key Ratios Overview

M.Cap (₹)19.13 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book0.57
Book Value1.59
EPS (TTM)-0.01
Face Value1.00
ROE (%)0.44

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KOTYARK-TNSE
SHREEGANES-XNSE
LTP
1W Low
1W High
Market cap (₹)
31.21+0.47 (1.53%)
30.55
32.35
366Cr
0.48+0 (0.00%)
0.46
0.48
19Cr

Key Highlights of Shree Ganesh Bio-Tech (India) Ltd’s P&L

In 2025-03-31, Shree Ganesh Bio-Tech (India) Ltd reported total revenue of ₹22.96Cr, compared with ₹20.28Cr in 2024-03-31, reflecting Shree Ganesh Bio-Tech (India) Ltd turnover.

Depreciation was ₹5000 crore and finance costs were ₹0 crore in 2025-03-31

Profit Before Tax (PBT) has been ₹38.69Lakh in 2025-03-31 as compared to ₹85.49Lakh in 2024-03-31.

Net Profit (PAT) was ₹27.84Lakh in 2025-03-31 compared with ₹62.07Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.01 in 2025-03-31, compared with ₹0.02 in 2024-03-31.